The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Controlled Release Drug Delivery-Global Market Insights and Sales Trends 2024
Synopsis
Controlled drug delivery is one which delivers the drug at a predetermined rate, for locally or systemically, for a specified period of time.
The global Controlled Release Drug Delivery market size is expected to reach US$ 74320 million by 2029, growing at a CAGR of 7.9% from 2023 to 2029. The market is mainly driven by the significant applications of Controlled Release Drug Delivery in various end use industries. The expanding demands from the Metered Dose Inhalers, Injectables, Transdermal and Ocular Patches and Infusion Pumps, are propelling Controlled Release Drug Delivery market. Wurster Technique, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Coacervation segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Controlled Release Drug Delivery, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Controlled Release Drug Delivery market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Controlled Release Drug Delivery market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Controlled Release Drug Delivery sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Controlled Release Drug Delivery covered in this report include Depomed, Coating Place, Corium, Johnson and Johnson, Alkermes, Pfizer, Orbis Biosciences, Capsugel and Merck, etc.
The global Controlled Release Drug Delivery market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Depomed
Coating Place
Corium
Johnson and Johnson
Alkermes
Pfizer
Orbis Biosciences
Capsugel
Merck
Aradigm
Global Controlled Release Drug Delivery market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Controlled Release Drug Delivery market, Segment by Type:
Wurster Technique
Coacervation
Micro Encapsulation
Implants
Transdermal
Targeted Delivery
Others
Global Controlled Release Drug Delivery market, by Application
Metered Dose Inhalers
Injectables
Transdermal and Ocular Patches
Infusion Pumps
Oral Controlled-Drug Delivery Systems
Drug Eluting Stents
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Controlled Release Drug Delivery companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Controlled drug delivery is one which delivers the drug at a predetermined rate, for locally or systemically, for a specified period of time.
The global Controlled Release Drug Delivery market size is expected to reach US$ 74320 million by 2029, growing at a CAGR of 7.9% from 2023 to 2029. The market is mainly driven by the significant applications of Controlled Release Drug Delivery in various end use industries. The expanding demands from the Metered Dose Inhalers, Injectables, Transdermal and Ocular Patches and Infusion Pumps, are propelling Controlled Release Drug Delivery market. Wurster Technique, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Coacervation segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Controlled Release Drug Delivery, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Controlled Release Drug Delivery market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Controlled Release Drug Delivery market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Controlled Release Drug Delivery sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Controlled Release Drug Delivery covered in this report include Depomed, Coating Place, Corium, Johnson and Johnson, Alkermes, Pfizer, Orbis Biosciences, Capsugel and Merck, etc.
The global Controlled Release Drug Delivery market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Depomed
Coating Place
Corium
Johnson and Johnson
Alkermes
Pfizer
Orbis Biosciences
Capsugel
Merck
Aradigm
Global Controlled Release Drug Delivery market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Controlled Release Drug Delivery market, Segment by Type:
Wurster Technique
Coacervation
Micro Encapsulation
Implants
Transdermal
Targeted Delivery
Others
Global Controlled Release Drug Delivery market, by Application
Metered Dose Inhalers
Injectables
Transdermal and Ocular Patches
Infusion Pumps
Oral Controlled-Drug Delivery Systems
Drug Eluting Stents
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Controlled Release Drug Delivery companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Controlled Release Drug Delivery
1.1 Controlled Release Drug Delivery Market Overview
1.1.1 Controlled Release Drug Delivery Product Scope
1.1.2 Controlled Release Drug Delivery Market Status and Outlook
1.2 Global Controlled Release Drug Delivery Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Controlled Release Drug Delivery Market Size by Region (2018-2029)
1.4 Global Controlled Release Drug Delivery Historic Market Size by Region (2018-2023)
1.5 Global Controlled Release Drug Delivery Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Controlled Release Drug Delivery Market Size (2018-2029)
1.6.1 North America Controlled Release Drug Delivery Market Size (2018-2029)
1.6.2 Europe Controlled Release Drug Delivery Market Size (2018-2029)
1.6.3 Asia-Pacific Controlled Release Drug Delivery Market Size (2018-2029)
1.6.4 Latin America Controlled Release Drug Delivery Market Size (2018-2029)
1.6.5 Middle East & Africa Controlled Release Drug Delivery Market Size (2018-2029)
2 Controlled Release Drug Delivery Market by Type
2.1 Introduction
2.1.1 Wurster Technique
2.1.2 Coacervation
2.1.3 Micro Encapsulation
2.1.4 Implants
2.1.5 Transdermal
2.1.6 Targeted Delivery
2.1.7 Others
2.2 Global Controlled Release Drug Delivery Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Controlled Release Drug Delivery Historic Market Size by Type (2018-2023)
2.2.2 Global Controlled Release Drug Delivery Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Controlled Release Drug Delivery Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Controlled Release Drug Delivery Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Controlled Release Drug Delivery Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Controlled Release Drug Delivery Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Controlled Release Drug Delivery Revenue Breakdown by Type (2018-2029)
3 Controlled Release Drug Delivery Market Overview by Application
3.1 Introduction
3.1.1 Metered Dose Inhalers
3.1.2 Injectables
3.1.3 Transdermal and Ocular Patches
3.1.4 Infusion Pumps
3.1.5 Oral Controlled-Drug Delivery Systems
3.1.6 Drug Eluting Stents
3.2 Global Controlled Release Drug Delivery Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Controlled Release Drug Delivery Historic Market Size by Application (2018-2023)
3.2.2 Global Controlled Release Drug Delivery Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Controlled Release Drug Delivery Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Controlled Release Drug Delivery Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Controlled Release Drug Delivery Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Controlled Release Drug Delivery Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Controlled Release Drug Delivery Revenue Breakdown by Application (2018-2029)
4 Controlled Release Drug Delivery Competition Analysis by Players
4.1 Global Controlled Release Drug Delivery Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Controlled Release Drug Delivery as of 2022)
4.3 Date of Key Players Enter into Controlled Release Drug Delivery Market
4.4 Global Top Players Controlled Release Drug Delivery Headquarters and Area Served
4.5 Key Players Controlled Release Drug Delivery Product Solution and Service
4.6 Competitive Status
4.6.1 Controlled Release Drug Delivery Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Depomed
5.1.1 Depomed Profile
5.1.2 Depomed Main Business
5.1.3 Depomed Controlled Release Drug Delivery Products, Services and Solutions
5.1.4 Depomed Controlled Release Drug Delivery Revenue (US$ Million) & (2018-2023)
5.1.5 Depomed Recent Developments
5.2 Coating Place
5.2.1 Coating Place Profile
5.2.2 Coating Place Main Business
5.2.3 Coating Place Controlled Release Drug Delivery Products, Services and Solutions
5.2.4 Coating Place Controlled Release Drug Delivery Revenue (US$ Million) & (2018-2023)
5.2.5 Coating Place Recent Developments
5.3 Corium
5.3.1 Corium Profile
5.3.2 Corium Main Business
5.3.3 Corium Controlled Release Drug Delivery Products, Services and Solutions
5.3.4 Corium Controlled Release Drug Delivery Revenue (US$ Million) & (2018-2023)
5.3.5 Johnson and Johnson Recent Developments
5.4 Johnson and Johnson
5.4.1 Johnson and Johnson Profile
5.4.2 Johnson and Johnson Main Business
5.4.3 Johnson and Johnson Controlled Release Drug Delivery Products, Services and Solutions
5.4.4 Johnson and Johnson Controlled Release Drug Delivery Revenue (US$ Million) & (2018-2023)
5.4.5 Johnson and Johnson Recent Developments
5.5 Alkermes
5.5.1 Alkermes Profile
5.5.2 Alkermes Main Business
5.5.3 Alkermes Controlled Release Drug Delivery Products, Services and Solutions
5.5.4 Alkermes Controlled Release Drug Delivery Revenue (US$ Million) & (2018-2023)
5.5.5 Alkermes Recent Developments
5.6 Pfizer
5.6.1 Pfizer Profile
5.6.2 Pfizer Main Business
5.6.3 Pfizer Controlled Release Drug Delivery Products, Services and Solutions
5.6.4 Pfizer Controlled Release Drug Delivery Revenue (US$ Million) & (2018-2023)
5.6.5 Pfizer Recent Developments
5.7 Orbis Biosciences
5.7.1 Orbis Biosciences Profile
5.7.2 Orbis Biosciences Main Business
5.7.3 Orbis Biosciences Controlled Release Drug Delivery Products, Services and Solutions
5.7.4 Orbis Biosciences Controlled Release Drug Delivery Revenue (US$ Million) & (2018-2023)
5.7.5 Orbis Biosciences Recent Developments
5.8 Capsugel
5.8.1 Capsugel Profile
5.8.2 Capsugel Main Business
5.8.3 Capsugel Controlled Release Drug Delivery Products, Services and Solutions
5.8.4 Capsugel Controlled Release Drug Delivery Revenue (US$ Million) & (2018-2023)
5.8.5 Capsugel Recent Developments
5.9 Merck
5.9.1 Merck Profile
5.9.2 Merck Main Business
5.9.3 Merck Controlled Release Drug Delivery Products, Services and Solutions
5.9.4 Merck Controlled Release Drug Delivery Revenue (US$ Million) & (2018-2023)
5.9.5 Merck Recent Developments
5.10 Aradigm
5.10.1 Aradigm Profile
5.10.2 Aradigm Main Business
5.10.3 Aradigm Controlled Release Drug Delivery Products, Services and Solutions
5.10.4 Aradigm Controlled Release Drug Delivery Revenue (US$ Million) & (2018-2023)
5.10.5 Aradigm Recent Developments
6 North America
6.1 North America Controlled Release Drug Delivery Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Controlled Release Drug Delivery Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Controlled Release Drug Delivery Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Controlled Release Drug Delivery Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Controlled Release Drug Delivery Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Controlled Release Drug Delivery Market Dynamics
11.1 Controlled Release Drug Delivery Industry Trends
11.2 Controlled Release Drug Delivery Market Drivers
11.3 Controlled Release Drug Delivery Market Challenges
11.4 Controlled Release Drug Delivery Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
